For all inquiries regarding Tissue Microarrays with survival data, please contact us at support@taibsbio.cn
首页 > 组织芯片 > > DLV1051
tissue microarray-DLV1051
  • 点数:
    105
    例数:
    35
    点样直径(mm):
    1
    厚度(µm):
    5
    行数:
    9
    列数:
    12
    组织阵列类型:
    FFPE
    种属:
    Human
DLV1051
加入收藏

描述: Liver cholangiocarcinoma tissue array with matched adjacent normal or cancer adjacent liver tissue, including pathology grade, TNM and clinical stage, 35 cases/105 cores

详情: Liver cholangiocarcinoma tissue microarray with matched adjacent normal or cancer adjacent liver tissue, containing 35 cases of cholangiocarcinoma, with matched adjacent normal or cancer adjacent liver tissue, duplicate cores of cancer, single core of adjacent normal or cancer adjacent tissue

应用程序: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

备注

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • 说明书列表
  • 重复病例
  • 下载说明书
图表:
Liver
  • Malignant(I)
  • Malignant(II)
  • Malignant(IIIA)
  • Malignant(IIIB)
  • NAT(*)
  • AT(*)
组织芯片
DLV1051
1
2
3
4
5
6
7
8
9
10
11
12
A
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
B
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
C
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
D
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
E
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
F
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
G
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
H
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
I
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
DLV1051
  • 年龄:
  • 性别:
  • 器官/解剖部位:
  • 病理诊断:
  • 等级:
  • 分期:
  • 阶段:
  • 组织ID.:
  • 类型:
位置 No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size
A1
1 51 F Liver Cholangiocarcinoma 1--2 T3N1M0 IIIB Malignant *
A2
2 51 F Liver Cholangiocarcinoma 1--2 T3N1M0 IIIB Malignant *
A3
3 51 F Liver Adjacent normal liver tissue * * * NAT *
A4
4 52 M Liver Cholangiocarcinoma with degenerate 2 T1N0M0 I Malignant 7*5
A5
5 52 M Liver Cholangiocarcinoma with degenerate 2 T1N0M0 I Malignant 7*5
A6
6 52 M Liver Adjacent normal liver tissue * * * NAT *
A7
7 60 F Liver Cholangiocarcinoma 2 T3N0M0 IIIA Malignant 7
A8
8 60 F Liver Cholangiocarcinoma 2 T3N0M0 IIIA Malignant 7
A9
9 60 F Liver Adjacent normal liver tissue * * * NAT *
A10
10 68 F Liver Cholangiocarcinoma 2 T3N0M0 IIIA Malignant 5
A11
11 68 F Liver Cholangiocarcinoma 2 T3N0M0 IIIA Malignant 5
A12
12 68 F Liver Adjacent normal liver tissue * * * NAT *
B1
13 64 M Liver Cholangiocarcinoma with degenerate 2 T3N0M0 IIIA Malignant 7
B2
14 64 M Liver Cholangiocarcinoma with degenerate 2 T3N0M0 IIIA Malignant 7
B3
15 64 M Liver Adjacent normal liver tissue * * * NAT *
B4
16 68 F Liver Cholangiocarcinoma 2 T2N0M0 II Malignant 4.0*3.5*3
B5
17 68 F Liver Cholangiocarcinoma 2 T2N0M0 II Malignant 4.0*3.5*3
B6
18 68 F Liver Adjacent normal liver tissue * * * NAT *
B7
19 50 F Liver Cholangiocarcinoma 2 T3N1M0 IIIB Malignant *
B8
20 50 F Liver Cholangiocarcinoma 2 T3N1M0 IIIB Malignant *
B9
21 50 F Liver Adjacent normal liver tissue * * * NAT *
B10
22 54 M Liver Cholangiocarcinoma 2 T3N1M0 IIIB Malignant *
B11
23 54 M Liver Cholangiocarcinoma 2 T3N1M0 IIIB Malignant *
B12
24 54 M Liver Adjacent normal liver tissue * * * NAT *
C1
25 54 M Liver Cholangiocarcinoma 2 T3N1M0 IIIB Malignant *
C2
26 54 M Liver Cholangiocarcinoma 2 T3N1M0 IIIB Malignant *
C3
27 54 M Liver Cancer adjacent liver tissue * * * AT *
C4
28 59 M Liver Cholangiocarcinoma 2 T3N1M0 IIIB Malignant *
C5
29 59 M Liver Cholangiocarcinoma (necrosis) * T3N1M0 IIIB Malignant *
C6
30 59 M Liver Adjacent normal liver tissue * * * NAT *
C7
31 63 M Liver Cholangiocarcinoma (sparse) 2 T3N0M0 IIIA Malignant *
C8
32 63 M Liver Cholangiocarcinoma (sparse) 2 T3N0M0 IIIA Malignant *
C9
33 63 M Liver Adjacent normal liver tissue * * * NAT *
C10
34 71 M Liver Cholangiocarcinoma 2 T2N1M0 IIIB Malignant 8*8
C11
35 71 M Liver Cholangiocarcinoma 2 T2N1M0 IIIB Malignant 8*8
C12
36 71 M Liver Cancer adjacent liver tissue * * * AT *
D1
37 65 F Liver Cholangiocarcinoma 2 T2N0M0 II Malignant 3.3*2.4
D2
38 65 F Liver Cholangiocarcinoma 2 T2N0M0 II Malignant 3.3*2.4
D3
39 65 F Liver Cancer adjacent liver tissue * * * AT *
D4
40 49 M Liver Cholangiocarcinoma 2 T4N0M0 IIIB Malignant 3*2.5
D5
41 49 M Liver Cholangiocarcinoma 2 T4N0M0 IIIB Malignant 3*2.5
D6
42 49 M Liver Cancer adjacent liver tissue * * * AT *
D7
43 60 M Liver Cholangiocarcinoma 2 T2N0M0 II Malignant *
D8
44 60 M Liver Cholangiocarcinoma 2 T2N0M0 II Malignant *
D9
45 60 M Liver Cancer adjacent liver tissue * * * AT *
D10
46 55 M Liver Cholangiocarcinoma 2 T3N0M0 IIIA Malignant 5*4
D11
47 55 M Liver Cholangiocarcinoma 2 T3N0M0 IIIA Malignant 5*4
D12
48 55 M Liver Cancer adjacent liver tissue * * * AT *
E1
49 56 F Liver Cholangiocarcinoma 2 T2N0M0 II Malignant 4
E2
50 56 F Liver Cholangiocarcinoma 2 T2N0M0 II Malignant 4
E3
51 56 F Liver Adjacent normal liver tissue * * * NAT *
E4
52 54 F Liver Cholangiocarcinoma 2 T3N0M0 IIIA Malignant 6*2.5
E5
53 54 F Liver Cholangiocarcinoma 2 T3N0M0 IIIA Malignant 6*2.5
E6
54 54 F Liver Cancer adjacent liver tissue * * * AT *
E7
55 42 M Liver Cholangiocarcinoma 2 T1N1M0 IIIB Malignant 6
E8
56 42 M Liver Cholangiocarcinoma 2 T1N1M0 IIIB Malignant 6
E9
57 42 M Liver Adjacent normal liver tissue * * * NAT *
E10
58 68 M Liver Cholangiocarcinoma 2--3 T3N0M0 IIIA Malignant 5
E11
59 68 M Liver Cholangiocarcinoma 2--3 T3N0M0 IIIA Malignant 5
E12
60 68 M Liver Adjacent normal liver tissue * * * NAT *
F1
61 60 F Liver Cholangiocarcinoma 2--3 T2aN0M0 II Malignant 3*2.5*2.5
F2
62 60 F Liver Cholangiocarcinoma 2--3 T2aN0M0 II Malignant 3*2.5*2.5
F3
63 60 F Liver Cancer adjacent liver tissue * * * AT *
F4
64 41 M Liver Cholangiocarcinoma 2--3 T3N0M0 IIIA Malignant 4*3*3.0
F5
65 41 M Liver Cholangiocarcinoma with necrosis 2--3 T3N0M0 IIIA Malignant 4*3*3.0
F6
66 41 M Liver Cancer adjacent liver tissue * * * AT *
F7
67 65 F Liver Cholangiocarcinoma 3 T3N0M0 IIIA Malignant 8*7
F8
68 65 F Liver Cholangiocarcinoma with necrosis 3 T3N0M0 IIIA Malignant 8*7
F9
69 65 F Liver Adjacent normal liver tissue * * * NAT *
F10
70 63 M Liver Cholangiocarcinoma 3 T2aN0M0 II Malignant 5
F11
71 63 M Liver Cholangiocarcinoma 3 T2aN0M0 II Malignant 5
F12
72 63 M Liver Cancer adjacent liver tissue * * * AT *
G1
73 50 M Liver Cholangiocarcinoma with necrosis 3 T2N0M0 II Malignant *
G2
74 50 M Liver Cholangiocarcinoma (degeneration and necrosis) 3 T2N0M0 II Malignant *
G3
75 50 M Liver Adjacent normal liver tissue * * * NAT *
G4
76 54 M Liver Cholangiocarcinoma 3 T3N0M0 IIIA Malignant 6*2*1.8
G5
77 54 M Liver Cholangiocarcinoma 3 T3N0M0 IIIA Malignant 6*2*1.8
G6
78 54 M Liver Adjacent normal liver tissue * * * NAT *
G7
79 62 M Liver Cholangiocarcinoma with necrosis 3 T2aN0M0 II Malignant 6
G8
80 62 M Liver Cholangiocarcinoma 3 T2aN0M0 II Malignant 6
G9
81 62 M Liver Adjacent normal liver tissue * * * NAT *
G10
82 53 M Liver Cholangiocarcinoma 3 T3N0M0 IIIA Malignant *
G11
83 53 M Liver Cholangiocarcinoma 3 T3N0M0 IIIA Malignant *
G12
84 53 M Liver Cancer adjacent liver tissue * * * AT *
H1
85 46 M Liver Cholangiocarcinoma 3 T2aN0M0 II Malignant 4*3*2
H2
86 46 M Liver Cholangiocarcinoma 3 T2aN0M0 II Malignant 4*3*2
H3
87 46 M Liver Adjacent normal liver tissue * * * NAT *
H4
88 56 M Liver Cholangiocarcinoma * T4N1M0 IIIB Malignant 6
H5
89 56 M Liver Cholangiocarcinoma * T4N1M0 IIIB Malignant 6
H6
90 56 M Liver Adjacent normal liver tissue * * * NAT *
H7
91 42 M Liver Cholangiocarcinoma * T3N0M0 IIIA Malignant 3
H8
92 42 M Liver Cholangiocarcinoma * T3N0M0 IIIA Malignant 3
H9
93 42 M Liver Adjacent normal liver tissue * * * NAT *
H10
94 57 M Liver Cholangiocarcinoma * T3N0M0 IIIA Malignant 9
H11
95 57 M Liver Cholangiocarcinoma * T3N0M0 IIIA Malignant 9
H12
96 57 M Liver Adjacent normal liver tissue * * * NAT *
I1
97 58 M Liver Cholangiocarcinoma * T4N1M0 IIIB Malignant 6
I2
98 58 M Liver Cholangiocarcinoma * T4N1M0 IIIB Malignant 6
I3
99 58 M Liver Adjacent normal liver tissue * * * NAT *
I4
100 65 M Liver Cholangiocarcinoma * T3N0M0 IIIA Malignant 7
I5
101 65 M Liver Cholangiocarcinoma * T3N0M0 IIIA Malignant 7
I6
102 65 M Liver Adjacent normal liver tissue * * * NAT *
I7
103 52 F Liver Cholangiocarcinoma (sparse) * T3N0M0 IIIA Malignant *
I8
104 52 F Liver Cholangiocarcinoma * T3N0M0 IIIA Malignant *
I9
105 52 F Liver Cancer adjacent liver tissue * * * AT *
查找与该芯片存在重复病例的芯片:
如需了解产品规格方面的任何问题,请联系我们:support@arraysbank.com
0.090953s